Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr₹776 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹-1,502 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-1,502 Cr
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr
Mar2021₹776 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-1,502 Cr
Negative
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr
25.01
Mar2021 ₹776 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,013.8 Cr -1.2% 4% 62.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -1.9% -7.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹166,862.0 Cr 1.8% 3.3% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,912.0 Cr -0.5% -4% 29.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,891.0 Cr 0.2% -4.9% 6.6% Stock Analytics
CIPLA ₹99,591.5 Cr 0.5% -3.8% -17% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.2%

4%

62.1%

SENSEX

3.2%

5%

5.5%


You may also like the below Video Courses